REVERCE: a randomized phase II study of regorafenib followed by cetuximab versus the reverse sequence for previously treated metastatic colorectal cancer patients
暂无分享，去创建一个
E. Oki | T. Yamanaka | J. Furuse | Y. Ohashi | T. Yoshino | K. Akiyoshi | K. Shitara | Y. Komatsu | T. Denda | Y. Tsuji | Y. Kagawa | H. Okuda | Y. Hagiwara | T. Kato | K. Shinozaki | M. Asayama | Y. Kobayashi | T. Ando | Y. Kagawa | Y. Kobayashi | Yasushi Tsuji | Eiji Oki | Yasuo Komatsu | Hiroyuki Okuda | Yasuhiro Hagiwara | Y. Ohashi